A new drug could dramatically ease the pain and misery of the 60,000 people in the UK who suffer from rheumatoid arthritis.

Biological response modifiers are a class of drugs used to treat rheumatoid arthritis (RA). Your doctor may suggest that you start right after your diagnosis, which can help address joint damage.

The biologic DMARDs rituximab and abatacept were associated with an increased risk for incident cancers in patients with RA ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Research reveals a higher cancer risk for rheumatoid arthritis patients using certain biologics, emphasizing the need for ...

Patients with both RA and metabolic syndrome demonstrated lower response rates to TNF inhibitor and non-TNF inhibitor therapies.

SetPoint Medical’s vagus nerve stimulator offers another treatment option for patients who do not properly respond to ...

ANB032 was well tolerated across all doses with no safety signals observedAD trial and all further investment in ANB032 will be ...

Higher MTX-PG concentrations were associated with improved disease activity among patients with RA receiving MTX therapy, though they were also linked to hepatotoxicity.